US Patent 11701388 Thrombosomes as an antiplatelet agent reversal agent
Patent 11701388 was granted and assigned to Cellphire Therapeutics on July, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 14, 2020
0
Date of Patent
July 18, 2023
0
Patent Applicant
Patent Application Number
16994377
0
Patent Citations
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11701388 Thrombosomes as an antiplatelet agent reversal agent
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
